News
Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data ...
It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer ...
13h
MedPage Today on MSNWhat Happened to Our Brains During the Pandemic?"Longer follow-ups after the pandemic are needed to investigate persistent brain aging effects and their long-term ...
After Advent's Felix Pharma buyout, another deal is brewing in the vet medicine segment. Multiples and other investors of ...
Mainz, 22 July 2025. Boehringer Ingelheim Stiftung commits 7 million euros to support the EMBL Imaging Centre in Heidelberg. Boehringer Ingelheim Stiftung, Dr Friederike Keggenhoff, Officer, Web: ...
The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...
The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.
This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...
LEO Pharma and Boehringer Ingelheim have entered into a partnership to commercialise and advance the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results